{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:51:24Z","timestamp":1792086684365,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11151-7","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T11:37:22Z","timestamp":1748173042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stress hyperglycemia ratio as a mortality predictor in non-diabetic septic patients: a retrospective cohort analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Siyu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"8","key":"11151_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"issue":"11","key":"11151_CR2","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54(11):2450\u201364. https:\/\/doi.org\/10.1016\/j.immuni.2021.10.012.","journal-title":"Immunity"},{"issue":"3","key":"11151_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of Hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2016;193(3):259\u201372. https:\/\/doi.org\/10.1164\/rccm.201504-0781OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"11151_CR4","doi-asserted-by":"crossref","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020; 395(10219):200-211.10.1016\/s0140-6736(19)32989-7.","DOI":"10.1016\/S0140-6736(19)32989-7"},{"issue":"1","key":"11151_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","volume":"24","author":"M Bauer","year":"2020","unstructured":"Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. https:\/\/doi.org\/10.1186\/s13054-020-02950-2.","journal-title":"Crit Care"},{"issue":"11","key":"11151_CR6","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","volume":"3","author":"K Leventogiannis","year":"2022","unstructured":"Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, et al. Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial. Cell Rep Med. 2022;3(11):100817. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100817.","journal-title":"Cell Rep Med"},{"key":"11151_CR7","doi-asserted-by":"crossref","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024; 25(1):19-28.10.1038\/s41590-023-01660-5.","DOI":"10.1038\/s41590-023-01660-5"},{"key":"11151_CR8","doi-asserted-by":"publisher","unstructured":"Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care Med. 2013;41(6):e93\u201394. https:\/\/doi.org\/10.1097\/CCM.0b013e318283d124.","DOI":"10.1097\/CCM.0b013e318283d124"},{"issue":"3","key":"11151_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s11739-020-02507-9","volume":"16","author":"Y Zohar","year":"2021","unstructured":"Zohar Y, Zilberman Itskovich S, Koren S, Zaidenstein R, Marchaim D, Koren R. The association of diabetes and hyperglycemia with sepsis outcomes: a population-based cohort analysis. Intern Emerg Med. 2021;16(3):719\u201328. https:\/\/doi.org\/10.1007\/s11739-020-02507-9.","journal-title":"Intern Emerg Med"},{"key":"11151_CR10","doi-asserted-by":"crossref","unstructured":"van Vught LA, Wiewel MA, Klein Klouwenberg PM, Hoogendijk AJ, Scicluna BP, Ong DS et al. Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host Response. Crit Care Med. 2016; 44(7):1338-1346.10.1097\/ccm.0000000000001650.","DOI":"10.1097\/CCM.0000000000001650"},{"key":"11151_CR11","doi-asserted-by":"publisher","unstructured":"Marik PE, Raghavan M. Stress-hyperglycemia, insulin and Immunomodulation in sepsis. Intensive Care Med. 2004;30(5):748\u201356. https:\/\/doi.org\/10.1007\/s00134-004-2167-y.","DOI":"10.1007\/s00134-004-2167-y"},{"issue":"4","key":"11151_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4067\/s0034-98872018000400502","volume":"146","author":"L Aleman","year":"2018","unstructured":"Aleman L, Guerrero J. Sepsis hyperglycemia in the ICU: from the mechanism to the clinic. Rev Med Chil. 2018;146(4):502\u201310. https:\/\/doi.org\/10.4067\/s0034-98872018000400502.","journal-title":"Rev Med Chil"},{"key":"11151_CR13","doi-asserted-by":"crossref","unstructured":"Wernly B, Lichtenauer M, Hoppe UC, Jung C. Hyperglycemia in septic patients: an essential stress survival response in all, a robust marker for risk stratification in some, to be messed with in none. J Thorac Dis. 2016; 8(7):E621-624.10.21037\/jtd.2016.05.24.","DOI":"10.21037\/jtd.2016.05.24"},{"issue":"4","key":"11151_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2337\/dc21-1526","volume":"45","author":"J Yang","year":"2022","unstructured":"Yang J, Zheng Y, Li C, Gao J, Meng X, Zhang K, et al. The impact of the stress hyperglycemia ratio on Short-term and Long-term poor prognosis in patients with acute coronary syndrome: insight from a large cohort study in Asia. Diabetes Care. 2022;45(4):947\u201356. https:\/\/doi.org\/10.2337\/dc21-1526.","journal-title":"Diabetes Care"},{"issue":"1","key":"11151_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12933-024-02454-1","volume":"23","author":"H Esdaile","year":"2024","unstructured":"Esdaile H, Khan S, Mayet J, Oliver N, Reddy M, Shah ASV. The association between the stress hyperglycaemia ratio and mortality in cardiovascular disease: a meta-analysis and systematic review. Cardiovasc Diabetol. 2024;23(1):412. https:\/\/doi.org\/10.1186\/s12933-024-02454-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"11151_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12933-023-02005-0","volume":"22","author":"L Li","year":"2023","unstructured":"Li L, Zhao M, Zhang Z, Zhou L, Zhang Z, Xiong Y, et al. Prognostic significance of the stress hyperglycemia ratio in critically ill patients. Cardiovasc Diabetol. 2023;22(1):275. https:\/\/doi.org\/10.1186\/s12933-023-02005-0.","journal-title":"Cardiovasc Diabetol"},{"key":"11151_CR17","doi-asserted-by":"crossref","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023; 10(1):1.10.1038\/s41597-022-01899-x.","DOI":"10.1038\/s41597-023-01945-2"},{"key":"11151_CR18","doi-asserted-by":"publisher","unstructured":"Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O\u2019Dea H, Stranks SN, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015;100(12):4490\u20137. https:\/\/doi.org\/10.1210\/jc.2015-2660.","DOI":"10.1210\/jc.2015-2660"},{"key":"11151_CR19","doi-asserted-by":"crossref","unstructured":"Yan F, Chen X, Quan X, Wang L, Wei X, Zhu J. Association between the stress hyperglycemia ratio and 28-day all-cause mortality in critically ill patients with sepsis: a retrospective cohort study and predictive model establishment based on machine learning. Cardiovasc Diabetol. 2024; 23(1):163.10.1186\/s12933-024-02265-4.","DOI":"10.1186\/s12933-024-02265-4"},{"key":"11151_CR20","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/194503","author":"Y Xu","year":"2025","unstructured":"Xu Y, Yang J, Jiang Z, Liu P, Wang X. Association between stress-induced hyperglycemia ratio and sepsis risk in patients admitted to ICU. Adv Clin Exp Med. 2025. https:\/\/doi.org\/10.17219\/acem\/194503.","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"11151_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40001-025-02281-4","volume":"30","author":"S Zhang","year":"2025","unstructured":"Zhang S, Shen H, Wang Y, Ning M, Zhou J, Liang X, et al. Association between stress hyperglycemia ratio and all-cause mortality in critically ill patients with sepsis: results from the MIMIC-IV database. Eur J Med Res. 2025;30(1):42. https:\/\/doi.org\/10.1186\/s40001-025-02281-4.","journal-title":"Eur J Med Res"},{"issue":"7","key":"11151_CR22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407\u201320. https:\/\/doi.org\/10.1038\/nri.2017.36.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"11151_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13054-014-0503-3","volume":"18","author":"M Garcia-Alvarez","year":"2014","unstructured":"Garcia-Alvarez M, Marik P, Bellomo R. Sepsis-associated hyperlactatemia. Crit Care. 2014;18(5):503. https:\/\/doi.org\/10.1186\/s13054-014-0503-3.","journal-title":"Crit Care"},{"key":"11151_CR24","doi-asserted-by":"crossref","unstructured":"An Y, Xu BT, Wan SR, Ma XM, Long Y, Xu Y et al. The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol. 2023; 22(1):237.10.1186\/s12933-023-01965-7.","DOI":"10.1186\/s12933-023-01965-7"},{"key":"11151_CR25","doi-asserted-by":"crossref","unstructured":"Hu CM, Tien SC, Hsieh PK, Jeng YM, Chang MC, Chang YT et al. High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells. Cell Metab. 2019; 29(6):1334\u20131349.e1310.10.1016\/j.cmet.2019.02.005.","DOI":"10.1016\/j.cmet.2019.02.005"},{"key":"11151_CR26","doi-asserted-by":"publisher","first-page":"706908","DOI":"10.3389\/fphar.2021.706908","volume":"12","author":"F Yang","year":"2021","unstructured":"Yang F, Zeng F, Luo X, Lei Y, Li J, Lu S, et al. GLP-1 receptor: A new target for Sepsis. Front Pharmacol. 2021;12:706908. https:\/\/doi.org\/10.3389\/fphar.2021.706908.","journal-title":"Front Pharmacol"},{"issue":"1","key":"11151_CR27","doi-asserted-by":"publisher","first-page":"8632","DOI":"10.1038\/s41467-024-52815-3","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu L, Huang Z, Zhang J, Wang M, Yue T, Wang W, et al. Hypothalamus-sympathetic-liver axis mediates the early phase of stress-induced hyperglycemia in the male mice. Nat Commun. 2024;15(1):8632. https:\/\/doi.org\/10.1038\/s41467-024-52815-3.","journal-title":"Nat Commun"},{"key":"11151_CR28","doi-asserted-by":"crossref","unstructured":"Xiu F, Stanojcic M, Diao L, Jeschke MG. Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol. 2014; 2014:486403.10.1155\/2014\/486403.","DOI":"10.1155\/2014\/486403"},{"key":"11151_CR29","doi-asserted-by":"crossref","unstructured":"An Y, Geng K, Wang HY, Wan SR, Ma XM, Long Y et al. Hyperglycemia-induced STING signaling activation leads to aortic endothelial injury in diabetes. Cell Commun Signal. 2023; 21(1):365.10.1186\/s12964-023-01393-w.","DOI":"10.1186\/s12964-023-01393-w"},{"issue":"744","key":"11151_CR30","doi-asserted-by":"publisher","first-page":"eadg5768","DOI":"10.1126\/scitranslmed.adg5768","volume":"16","author":"N Khan","year":"2024","unstructured":"Khan N, Kumar V, Li P, Schlapbach LJ, Boyd AW, Coulthard MG, et al. Inhibiting Eph\/ephrin signaling reduces vascular leak and endothelial cell dysfunction in mice with sepsis. Sci Transl Med. 2024;16(744):eadg5768. https:\/\/doi.org\/10.1126\/scitranslmed.adg5768.","journal-title":"Sci Transl Med"},{"key":"11151_CR31","unstructured":"Vallet B. Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care. 2003; 7(2):130-138.10.1186\/cc1864."},{"key":"11151_CR32","doi-asserted-by":"crossref","unstructured":"Wei X, Min Y, Yu J, Wang Q, Wang H, Li S et al. Admission Blood Glucose Is Associated With the 30-Days Mortality in Septic Patients: A Retrospective Cohort Study. Front Med (Lausanne). 2021; 8:757061.10.3389\/fmed.2021.757061.","DOI":"10.3389\/fmed.2021.757061"},{"key":"11151_CR33","doi-asserted-by":"crossref","unstructured":"Zhang C, Shen HC, Liang WR, Ning M, Wang ZX, Chen Y et al. Relationship between stress hyperglycemia ratio and allcause mortality in critically ill patients: Results from the MIMIC-IV database. Front Endocrinol (Lausanne). 2023; 14:1111026.10.3389\/fendo.2023.1111026.","DOI":"10.3389\/fendo.2023.1111026"},{"key":"11151_CR34","doi-asserted-by":"crossref","unstructured":"Liu J, Zhou Y, Huang H, Liu R, Kang Y, Zhu T et al. Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from american MIMIC-IV and the chinese CIN-II study. Cardiovasc Diabetol. 2023; 22(1):281.10.1186\/s12933-023-02012-1.","DOI":"10.1186\/s12933-023-02012-1"},{"key":"11151_CR35","doi-asserted-by":"crossref","unstructured":"Li L, Ding L, Zheng L, Wu L, Hu Z, Liu L et al. Relationship between stress hyperglycemia ratio and acute kidney injury in patients with congestive heart failure. Cardiovasc Diabetol. 2024; 23(1):29.10.1186\/s12933-023-02105-x.","DOI":"10.1186\/s12933-023-02105-x"},{"key":"11151_CR36","doi-asserted-by":"crossref","unstructured":"Wei QC, Chen YW, Gao QY, Ren KD, Liu YB, He F et al. Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study. Cardiovasc Diabetol. 2023; 22(1):85.10.1186\/s12933-023-01812-9.","DOI":"10.1186\/s12933-023-01812-9"},{"key":"11151_CR37","doi-asserted-by":"crossref","unstructured":"Nakamura M, Oda S, Sadahiro T, Watanabe E, Abe R, Nakada TA et al. Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients. Crit Care. 2012; 16(2):R58.10.1186\/cc11301.","DOI":"10.1186\/cc11301"},{"key":"11151_CR38","doi-asserted-by":"crossref","unstructured":"Lu Z, Tao G, Sun X, Zhang Y, Jiang M, Liu Y et al. Association of Blood Glucose Level and Glycemic Variability With Mortality in Sepsis Patients During ICU Hospitalization. Front Public Health. 2022; 10:857368.10.3389\/fpubh.2022.857368.","DOI":"10.3389\/fpubh.2022.857368"},{"key":"11151_CR39","doi-asserted-by":"crossref","unstructured":"Ann Levesque C. Management of Diabetes in the Hospitalized Patient. Crit Care Nurs Clin North Am. 2025; 37(1):xi-xii.10.1016\/j.cnc.2024.11.001.","DOI":"10.1016\/j.cnc.2024.11.001"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11151-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11151-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T11:37:27Z","timestamp":1748173047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11151-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11151"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11151-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study followed the 1964 Declaration of Helsinki and its later amendments. All personally identifiable information has been anonymized to protect patient privacy. The Institutional Review Boards at both Massachusetts Institute of Technology (MIT) and Beth Israel Deaconess Medical Center (BIDMC) have approved this study, including the sharing of the research resource (Certification Number: 62864173), and waived the need for informed consent due to the thorough anonymization and deidentification of all patient information in the database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"752"}}